Bloomington Officials Reassure After Novo Workforce Cut

City leaders point to tight labor market as Novo Nordisk plans 400 job losses.

Apr. 2, 2026 at 9:06am

Got story updates? Submit your updates here. ›

Bloomington, Indiana officials are seeking to reassure residents after the announcement that Novo Nordisk, a major biotech employer in the city, will be cutting 400 jobs. Despite the impending layoffs, local economic development leaders say the city's job market remains strong, citing Bloomington's low 2.4% unemployment rate in December as a sign of the underlying economic strength.

Why it matters

The Novo Nordisk layoffs represent a significant blow to Bloomington's flagship biotech sector, which has been a key driver of the local economy. However, city leaders are emphasizing that the broader job market remains tight, suggesting the displaced workers may be able to find new opportunities relatively quickly.

The details

Novo Nordisk, a Danish pharmaceutical company, announced it will be cutting 400 jobs in Bloomington as part of a broader restructuring. Local economic development officials say the city's low 2.4% unemployment rate in December indicates the local job market remains strong enough to absorb the impact of the Novo layoffs.

  • Novo Nordisk announced the 400 job cuts in Bloomington in April 2026.
  • Bloomington's unemployment rate was 2.4% in December 2025.

The players

Novo Nordisk

A Danish pharmaceutical company that is a major employer in Bloomington, Indiana.

Bloomington

The city in Indiana where Novo Nordisk has a significant presence and is a key part of the local biotech sector.

Got photos? Submit your photos here. ›

The takeaway

While the Novo Nordisk layoffs represent a significant setback for Bloomington's biotech industry, the city's broader economic indicators suggest the local job market remains tight, potentially allowing displaced workers to find new opportunities relatively quickly.